Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.

Eitemau Tebyg

• Nuclear uptake of 1,25-dihydroxy[3H]cholecalciferol in dispersed fibroblasts cultured from normal human skin.
  gan: Eil, C, et al.
  Cyhoeddwyd: (1981)
• Failure to heal D-deficiency rickets and suppress secondary hyperparathyroidism with conventional doses of 1,25-dihydroxy vitamin D3.
  gan: Cundy, T, et al.
  Cyhoeddwyd: (1982)
• Failure to heal vitamin D-deficiency rickets and suppress secondary hyperparathyroidism with conventional doses of 1,25-dihydroxy vitamin D3.
  gan: Gillies, D R, et al.
  Cyhoeddwyd: (1982)
• Effect of 1,25-dihydroxy-vitamin D(3) in experimental sepsis
  gan: Møller, Søren, et al.
  Cyhoeddwyd: (2007)
• Double-blind trial of oral 1,25-dihydroxy vitamin D3 versus placebo in asymptomatic hyperparathyroidism in patients receiving maintenance haemodialysis.
  gan: Memmos, D E, et al.
  Cyhoeddwyd: (1981)